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INTRODUCTION Table 1 Problems of the expedition doctor 
Increasing numbers of people are spending their time 
on expedition travel of one sort or another. Expeditions 
may involve high-altitude Himalayan climbing, jungle 
exploration or desert travel and may additionally 
involve a number of ‘adventurous activities’ such as 
parachuting, diving or caving. Scientific expeditions 
may lead to exposure to local flora and fauna. All these 
various activities, locations and exposures may present 
their own specific medical problems. Expedition mem- 
bers may have medical concerns and requirements 
for prophylactic measures prior to travel. They may 
become ill during the expedition or after return to their 
native country. Under some circumstances the same 
practitioner is responsible for advising them before 
departure, caring for them on the trip and advising 
them after their return. In other situations, each of the 
three phases of the expedition travel may involve several 
different health professionals. Practicing medicine prior 
to and while on expedition presents unique challenges 
that differ dramatically from those encountered in 
routine practice in a developed country: an overview 
of these challenges is illustrated in Table 1, and it is 
readily apparent that most of these relate to remoteness 
from colleagues and resources and to practicing in a 
potentially hostile environment. 
Infection causes many expedition medical problems. 
This may be the common infection seen in routine 
practice, such as respiratory, skin, soft tissue and urinary. 
Additionally, there may be the risk of the more esoteric 
infections related to ‘tropical travel’. Fear of infection is 
Corresponding author and reprint requests: 
Alastair R. 0. Miller, Department of Medicine, 
Kidderminster General Hospital, Bewdley Road, 
Kidderminster, DY12 6RJ, UK 
Tel: +44 1562 513 044 
E-mail: alandang.miller@btinternet.com 
Fax: +44 1562 513 016 
Remoteness 
of colleagues (therefore, nobody to d~scuss difficult medical cases 
with; may be easier with improving communication technology); 
of technical diagnostic and therapeutic equipment; 
of drugs and equipment (resupply may be especially difficult) 
Unfamiliar workplace 
Operating in a tent or on a small boat may be technically 
difficult 
Unfamiliar patients 
May be different racial backgrounds, different cultures, etc. 
Proximity of patients 
Having to live with patients in cramped circumstances may give 
rise to hfficulties 
‘Hostile environment’ 
Hot, cold, altitude 
‘Tropical disease’ 
Many expeditions involve travel in or through a developing 
country with poor sanitation and much infection in the local 
population. 
‘Dangerous pastimes’ 
Many expeditions involve potentially dangerous occupations 
such as mountaineering, diving or canoeing and there is 
therefore significant risk of accidents and trauma 
common among those visiting a developing country for 
the first time, although, in practice, the morbidity from 
trauma, especially road trafic accidents, may well exceed 
that from tropical and infectious disease 111. 
PREPARATION PRIOR TO TRAVEL 
This is not the place for a detailed account ofpre-travel 
preparation, as that can be found in many standard texts 
and reviews [ 2 ] .  However, certain features that distin- 
guish expedition travel from other ‘exotic’ holidays 
need to be highlighted. The most important role of 
any pre-travel consultation is providing information on 
how to limit risks of infection. This includes standard 
advice on avoidance of enteric infection in developing 
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countries. Expeditions can have particular problems 
with the provision of clean and adequate water supplies 
for their members, and expedition medical advisers 
may have to balance the risks of allowing members to 
drink potentially contaminated water against the risk of 
inadequate fluid intake leading to dehydration. 
VACCl N AT1 0 N 
Expedition members should receive standard vaccination 
advice and should be immunized against polio, tetanus, 
typhoid and hepatitis A. Pre-exposure prophylaxis of 
rabies with human diploid cell vaccine (HDCV) should 
certainly be considered. This is not recommended 
for the average traveler, as its administration does 
not obviate the need for follow-up post-exposure 
treatment in the event of a significant risk exposure. 
However, on an expedition, access to HDCV for 
post-exposure treatment may be difficult and rabies 
immune globulin totally unobtainable. Therefore, pre- 
exposure prophylaxis may ‘buy time’ and allow a 
member to return to receive appropriate post-exposure 
vaccination [3] .  Other vaccinations, such as meningo- 
coccal, Japanese and tick-borne encephalitis, may be 
advisable, depending on the nature of the trip and the 
precise itinerary. 
It is usually not possible to assemble expedition 
members prior to departure just for the purpose of 
administering vaccines, and therefore these are usually 
given by the member’s own GP or local travel clinic. 
However, if the expedition is having a pre-departure 
‘get together’ this represents an ideal opportunity to 
brief members about the risks of infection and how 
to avoid them. It is also often appropriate to offer 
vaccination, particularly with vaccine that may be 
expensive or difficult to obtain. Rabies vaccine can be 
given in one-tenth of the normal dose if it is 
administered intradermally rather than subcutaneously, 
and therefore one vial can be used to vaccinate 10 
members if they are assembled together. If such an 
assembly does not take place, it is sensible for the 
expedition doctor to write to all members and advise 
on a specific vaccination program so that everyone will 
have had the same vaccinations before departure. 
MALARIA PREVENTION 
Malarial prophylaxis may be required and may pose 
particular problems on an expedition. The mainstay of 
protection for the expeditioner as for any traveler is the 
avoidance of bites by malaria-infected mosquitoes. This 
may be more difficult without the screens, sprays and 
other features of corporate protection delivered in 
luxury accommodation. Advice on chemoprophylaxis 
is regularly published [4]. It is important that all 
members are following the same regimen, as it has long 
been recognized that inconsistent advice is one of the 
strongest predictors of poor adherence to a prophylactic 
regimen [ S ] .  It will be readily apparent to expedition 
members that some members (for example) are takmg 
daily medication and others are taking it on a weekly 
basis. Having chosen an appropriate regimen, it is 
important to maximize adherence to it by some form 
of team activity that encourages pill-taking (e.g. all 
taking them at specific times of day or with specific 
meals). One problem is when an expedition traverses a 
malarial area and then spends a lot of time outside that 
area. This occurs especially on Himalayan climbing or 
trekking expeditions that transit through Delhi or 
Kathmandu en route for the high mountains. It can be 
difficult to persuade members to take antimalarial 
tablets when they are sitting in the snow at 5000 m 
above sea level! 
EXPEDITION STORES 
The individual or team responsible for the health of the 
expedition members may include doctors, nurses, 
paramedics or completely untrained individuals. Any of 
these may have varying degrees of tropical/expedition/ 
infection experience, but for simplicity I shall refer to 
them as ‘the expehtion doctor’. Having given appro- 
priate pre-deployment advice, the next task is to 
assemble suitable medical stores to provide for the 
duration of the expedition. How much is taken 
depends on the size, duration and remoteness of the 
expedition and on the potential for resupply of vital 
drugs. The expedition doctor is often in a ‘no-win’ 
situation: if too many precious porters or beasts of 
burden are laden with medical stores, the expedition 
leader will not be pleased; however, if a vital drug 
supply is exhausted and resupply not possible, then the 
consequences may be tragic [6]. When developing the 
stores inventory, it is important to consider whether 
there is an intention to provide any medical care to the 
local inhabitants of villages that may be visited on the 
expedition, as this will have a major impact on 
the quantity and range of drugs and equipment taken. 
From the infection point of view, it is obviously 
desirable to take agents that can be used in many 
different situations. There is no one ideal agent that can 
be used for every clinical situation in every expedition 
member. It is unlikely that any microbiological data 
will be available to help with antibiotic choice, and so 
decisions must be empirical and made on clinical 
grounds. It is unlikely that organisms acquired in remote 
areas will have been exposed to major antibiotic pressure 
and they will therefore largely have retained their 
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antibiotic susceptibility. However, organisms acquired 
in urban areas of developing countries may be showing 
resistance as a result of unregulated ‘over the counter’ 
antibiotic use. This may particularly apply to gastro- 
intestinal organisms such as salmonellae and Esrherichia 
coli. 
INFECTION ON THE EXPEDITION 
Once the expedition is underway, its members may 
develop a variety of medical concerns and present to 
the expedition doctor. Usually, these problems are of a 
fairly minor nature and require symptomatic treatment 
for minor trauma, dyspepsia or headache. The most 
common infections in the expedition setting are gastro- 
intestinal and respiratory 
Upper respiratory infection 
Sore throats are an extremely common problem on 
expeditions and are often associated with changes in 
climate or altitude. Members will expect to receive 
symptomatic treatment [7]. The majority will settle and 
the indications for antimicrobial treatment should be 
the same on an expedition as in general practice, 
although the threshold for starting antibiotics will 
probably be lower. Amoxycillin is probably the most 
appropriate agent with an oral cephalosporin such as 
cefaclor or a macrolide as alternatives for the peni- 
cillin allergic. Clarithromycin has better gastrointestinal 
tolerance and has enhanced activity against Huemophilus 
i@ueizzae but erythromycin is cheaper. 
Chest infection 
The incidence of chest infection may vary according to 
the locale of the expedition and predisposing factors 
among the expedition members. Those going to high 
altitude are especially susceptible, and it may be difficult 
to distinguish clinically between infection and high- 
altitude pulmonary edema. There are few microbio- 
logical data on ‘expedition pneumonias’, but one 
would expect that causative organisms are similar to 
those encountered in the more routine community- 
acquired pneumonia and therefore should respond to 
the same antimicrobial agents. Once again, amoxycillin 
would be a logical first choice, with cefaclor or a 
macrolide as alternatives. The possibility of legionella 
infection should be borne in mind, as there will almost 
certainly have been transit through air-conditioned 
hotels, aeroplanes and terminal buildings. Parented 
co-amoxiclav would be appropriate for severe infection. 
A second-generation quinolone with enhanced anti- 
pneumococcal activity may be a useful addition to the 
armamentarium. 
Gastrointestinal infection 
Many expeditions involve travel through or to develop- 
ing countries, and therefore travelers’ diarrhea is 
common. Most will respond to symptomatic treatment 
with loperamide and hydration with simple fluids such 
as bottled water or possibly with oral rehydration 
solution. However, if the diarrhea is very severe or 
bloody or the patient is toxic, then antimicrobial agents 
should be offered and ciprofloxacin 500 mg twice daily 
for 2-3 days should be effective. Some recent work 
among British servicemen in Belize suggests that a 
single dose of ciprofloxacin may be effective [8] .  If 
the diarrhea persists and remains severe and bloody 
despite ciprofloxacin, then amoebic infection should 
be considered. If it is very persistent and becomes 
malabsorptive in nature, then giardiasis should be con- 
sidered [9]. Both of these conditions can be effectively 
treated with oral metronidazole. 
If an expedition member develops an acute 
abdomen with peritonitis, then this may be settled 
by parented co-amoxiclav if evacuation or  surgical 
management is not possible. 
Septicemia 
Septicemia is a rare problem on expeditions and clearly 
represents a difficult management problem with minimal 
access to diagnostic aids and physiologic monitoring. 
Supplies of parented fluid may also be severely limited. 
As in more conventional practice, the most likely 
sources are the gut, chest, skin and urine. Co-amoxiclav 
administered parenterally should lull most likely patho- 
gens. Alternatives would be second- or third-generation 
cephalosporins such as cefuroxime or cefotaxime 
although the latter is less effective against Gram-positive 
agents and both would require the addition of metro- 
nidazole to cover Gram-negative anaerobic infection. 
Meningococcal disease is more common in 
northern India and Nepal and has been a problem in 
East Africa as well as in Saudi Arabia and the well- 
known ‘meningitis belt’ of West Afiica. Therefore, 
meningococcal meningitis and septicemia is a theoretical 
problem. Although co-amoxiclav is not licensed for the 
treatment of meningitis, the amoxycillin component 
will penetrate inflamed meninges [lo] and achieve 
therapeutic concentrations, and if it is the only 
parented agent available, then it could be used. Some 
expeditions may wish to carry supplies of a third- 
generation cephalosporin such as cefotaxime or 
ceftriaxone to treat suspected meningitis. Others may 
choose to take supplies of benzylpenicillin. 
Urinary infection 
This is not usually a common problem but dehydration 
and poor hygiene may predispose to it. Once again, 
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amoxycillin, co-amoxiclav or a quinolone should be 
effective. 
Skidsoft tissuebonefioint infection 
Skin and soft tissue infections (SSTIs) occur frequently 
on expeditions as sequelae to the cuts and abrasions 
sustained while traversing rough terrain, and scrupulous 
attention should be paid to wound cleansing. The 
moist atmosphere in jungle expeditions may worsen the 
problem. Initial management consists of good wound 
toilet and regular dressing, but if a spreading celldtis is 
developing, then co-amoxiclav should be given. This 
should also be effective in the treatment of major 
wound infections following trauma and in the treat- 
ment of bone and joint infection. For those who are 
allergic, cefaclor or a macrolide are appropriate alter- 
natives. Fungal skin infections are common and, 
in particular, tinea infections of the feet can cause 
significant problems. The risks can be reduced by 
commonsense foot care and the use of undecoenoate 
dusting powder. Treatment is with miconazole or 
clotrimazole cream. Parasitic skin infestation with scabies 
and lice is also a potential problem (especially if local 
accommodation is used) and a malathion preparation 
should be available to treat both conditions. 
Miscellaneous infections 
The possibility of malaria must, of course, be con- 
sidered in anyone who has a fever and has traveled 
through an endemic area in the few weeks prior to 
presentation. The expedition doctor may have to have 
a low threshold for giving empirical antimalarial 
treatment, depending on the location, itinerary and 
duration of the expedtion, together with the clinical 
presentation of the patient. He or she will need to have 
quinine preparations available for treatment in most 
circumstances. In the appropriate context, ricketsial 
infection is also a possibility, and in particular tick 
typhus in Africa and scrub typhus in South East Asia. 
Daily doxycycline is the most appropriate treatment 
(there is a significant incidence of gastrointestinal 
symptoms and photosensitivity). 
Dental infection is a potential risk and all expedition 
members should have had a dental check-up before 
departure. Co-amoxiclav should be effective treatment 
for most dental infections with metronidazole as an 
alternative. 
ANTIBIOTICS FOR EXPEDITIONS 
As discussed above, the exact formulary which is taken 
on any expedition will depend on the size, duration, 
activity and location of the trip. It will also depend on 
the expedition budget. Although some pharmaceutical 
companies may be prepared to supply expeditions at 
reduced prices, the cost of assembling the medical 
stores can be not inconsiderable and compromises will 
have to be made. It would seem reasonable to take 
amoxycdlin as a cheap broad-spectrum agent to treat 
‘chest infection’, upper respiratory infection such as 
sinusitis or otitis media which do not seem to be 
responding to symptomatic measures, and urinary tract 
infection. It would also seem reasonable to take a supply 
of co-amoxiclav (amoxycillin/clavulanate) to broaden 
the spectrum for someone not responding to amoxy- 
cilhn and to treat skin and soft tissue infection. 
Parented co-amoxiclav should also be available for the 
infrequent occasions when such an agent might be 
necessary (an alternative parented agent would be a 
second-generation cephalosporin). It would also be 
sensible to have a quinolone such as ciprofloxacin 
available to treat severe enteric infection and to provide 
an extra broad-spectrum agent for urinary infection in 
particular. It is helpful to know before the expedition 
departs whether any members have specific drug 
allergies, as this might necessitate the provision of 
specific alternatives. A summary of recommended 
agents is given in Table 2. 
Table 2 Suggested antibiotics 
Essential items (minimum no members with known penicillin 
allere) 
Oral amoxycillin 
Oral co-amoxiclav 
Injectable co-amoxiclav 
Oral ciprofloxacin 
Additional agents according to area of travel, budget activities, 
allergies, etc. 
Injectable cephalosporin 
Injectable benzylpenicillin 
Oral metronidazole 
Rectal metronidazole 
Oral doxycycline 
Oral clarithromycin 
See text for details. 
INFECTION AFTER THE EXPEDITION 
It is generally accepted that there is little value in 
routine medical screening following time spent over- 
seas. However, clearly, if the expedition has taken place 
in a tropical country, then any symptoms such as fever 
and diarrhea should be investigated promptly and 
thoroughly. The differential diagnoses and investigative 
pathways do not differ significantly from those of more 
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conventional overseas travel, except that expedition 
members may be at somewhat enhanced risk of the 
more esoteric infections by virtue of their more sustained 
and intimate exposure to indigenous populations and 
pathogens. 
CONCLUSIONS 
The practice of medicine on expeditions differs signi- 
ficantly from that in more conventional settings. Many 
of the medical problems on expeditions are caused by 
infection. The risk of acquiring many of these can be 
reduced by sensible preparation (including vaccination) 
before the expedition and sensible behavior in the field. 
Illness caused by infection on expeditions usually has to 
be treated empirically on a ‘best guess’ basis and it is 
important to have a number of different antimicrobial 
agents available. Following return from expeditions, 
members may still be harboring potentially pathogenic 
organisms acquired overseas, and any appropriate symp- 
toms require active investigation. 
EDITORIAL COMMENT 
Travel- related infections 
Chi Microbiol It@ 1999; 5:  183 
In response to a massive increase in international travel, 
the 1990s has seen the development of organizations 
such as The International Society of Travel Medicine 
and The British Travel Health Association, which focus 
on and promote the health of travelers. Such organi- 
zations have an important educative role to play and 
it is likely that travel medicine will develop into a 
subspeciality of its own. While a significant proportion 
of the morbidity among travelers comes from non- 
infectious causes such as road traffic accidents and 
cardiovascular disease, infections continue to present a 
challenge to their health, more so on visits to resource- 
poor countries. There is increasing awareness of the 
role of travel in the spread of emerging infectious 
diseases [l] and the inevitable consequence that they 
may present as problems for diagnosis, treatment and 
prevention of spread in any part of the world. Thus, 
expertise in travel-related infection is a necessity for all 
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those practicing clinical microbiology/infection. The 
CMI Editorial Board has agreed to encourage the 
submission of articles and original papers on travel- 
related infection for publication in the Journal. The 
first in the series, from Dr Alastair Miller, appears in 
this issue. Dr Miller, himself an infectious disease 
physician, has first-hand experience of the medical care 
of expeditions to remote areas of the world, which 
is reflected in his clear and practical analysis of the 
problems posed by infection on expeditions. The 
Editors look forward to receiving further manuscripts 
on infection in relation to travel. 
Peter L. Chiodirii 
Editor, CMI 
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